Despite BMPs’ promise, their application remains contentious (35), with reported drawbacks including high costs and complications such as inflammatory reactions, hematoma, radiculopathy, heterotopic ossification, osteoclast activation, osteolysis, and tumorigenesis (36, 37). Here, CLN5 is linked to hematoma.